| Products/Services Used | Details | Operation |
|---|---|---|
| Proteins, Expression, Isolation and Analysis | … Surface expression of CAR-transduced T cells was detected by Protein L. Cells were incubated in 2ul biotinylated protein L (GenScript, USA) in a 0.1 ml volume of PBS for 45 min, washed twice, then incubated with 0.5ul SA-PE in a 0.1 ml volume of PBS for 15 min, washed … | Get A Quote |
Immunotherapy utilizing T cells genetically modified to express chimeric antigen receptors (CARs) is rapidly emerging as a promising novel treatment for hematological and nonhematological malignancies. In order to target the TKI-insensitive leukemia stem cells (LSCs) in chronic myeloid leukemia (CML) by CAR T cells， we chose CD26 as a cell surface tumor-associated antigen due to preferentially expression on LSCs. Additionally， CD26 has also been suggested to be a multipurpose therapeutic target for other cancer. Therefore， developing the CD26-targeting CAR T cells may be a promising therapy for not only LSCs but also other CD26+ cancer cells. We designed the second-generation CD26-targeting CAR utilizing... More
